FindTrial
Sign In

Long term biomonitoring and risk assessment of decabromodiphenylether (DBDE) in humans

Long term biomonitoring and risk assessment of decabromodiphenylether (DBDE) in humans - DBDE study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30004
Enrollment
330
Registered
2006-10-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endocrine disruption nvt

Interventions

None listed

Sponsors

Bromine Science and Environment Forum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: female 20-40 yr old

Exclusion criteria

Exclusion criteria: occupational exposure to DBDE

Design outcomes

Primary

MeasureTime frame
DecaDBE in human blood—

Secondary

MeasureTime frame
none—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)